Future Science Group
Browse
Supplementary materials (6).docx (51.59 kB)

Cost-effectiveness Analysis of Prolonged-Release Fampridine to Treat Walking Disability of Multiple Sclerosis in China - Supplementary materials

Download (51.59 kB)
dataset
posted on 2022-07-27, 09:46 authored by Xinran Zhao, Han Yang, Tian Wei, Jin Zhao, Jun Liu, Zhe Huang, Lin Zhu, Yinan Zhao, Wei Li

  

Discussion Guides prepared for the interview with

Multiple Sclerosis Related Clinical KOL

July 2021

Funding

Biogen, (Grant / Award Number:)

History

Usage metrics

    Journal of Comparative Effectiveness Research

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC